Roche Partners With UCB On Anti-Tau Alzheimer’s Drug

 
• By Joseph Haas
  
Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
Roche takes another shot in Alzheimer's by licensing UCB anti-tau candidate

More from Deals

More from Business